Asthma News

Mepolizumab reduced the need for maintenance oral corticosteroids and systemic corticosteroid bursts among patients with severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Children and adolescents with allergic asthma and serum IgE levels that exceed approved dosing ranges still benefitted from omalizumab, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

In response to a research group’s proposal for over-the-counter availability of rescue inhalers for asthma, another group advised that the benefits and risks of this recommendation need consideration, according to a letter in JAMA.

Patients with asthma treated with biologics did not have higher rates of SARS-CoV-2 infection than the general population, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Among physically inactive adults with asthma, exercise intensity modified the acute inflammatory response to exercise, researchers reported in Annals of the American Thoracic Society.

Hospital readmissions for asthma among children aged 3 years and older in Australia increased from 2017 to 2018, researchers reported in Journal of Asthma.

Climate change is having a substantial negative impact on allergies, asthma and other respiratory disorders, according to a presentation given during the European Academy of Allergy and Clinical Immunology Hybrid Congress.

Patients with asthma who began triple therapy with a single inhaler had better adherence than patients on triple therapy with multiple inhalers, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Maintenance and reliever therapy using inhaled corticosteroids and formoterol was associated with lower risk for asthma exacerbations, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The biologics mepolizumab, dupilumab and benralizumab showed minimal differences in efficacy and safety in treating eosinophilic asthma, according to a review of eight studies published in The Journal of Allergy and Clinical Immunology.